Does the difference between PART and Alzheimer's disease lie in the age-related changes in cerebral arteries that trigger the accumulation of Aβ and propagation of tau? (Q48260410)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Does the difference between PART and Alzheimer's disease lie in the age-related changes in cerebral arteries that trigger the accumulation of Aβ and propagation of tau?	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25814152

Does the difference between PART and Alzheimer's disease lie in the age-related changes in cerebral arteries that trigger the accumulation of Aβ and propagation of tau? (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25814152

Alzheimer's disease

0 references

John Anthony Hardy

4

object named as

John Hardy

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

author name string

Roy O Weller

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25814152

Cheryl A Hawkes

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25814152

Roxana O Carare

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25814152

publication date

27 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25814152

Acta Neuropathologica

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25814152

129

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25814152

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25814152

763-766

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25814152

Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Cholinergic deafferentation of the rabbit cortex: a new animal model of Abeta deposition

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Are cases with tau pathology occurring in the absence of Aβ deposits part of the AD-related pathological process?

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Review: cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

A three-dimensional human neural cell culture model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Primary age-related tauopathy (PART): a common pathology associated with human aging

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Disruption of arterial perivascular drainage of amyloid-β from the brains of mice expressing the human APOE ε4 allele

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Aβ-degrading enzymes: potential for treatment of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Blood-brain barrier breakdown in the aging human hippocampus

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

The Cerebrovascular Basement Membrane: Role in the Clearance of β-amyloid and Cerebral Amyloid Angiopathy

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Tau aggregation and its interplay with amyloid-β.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Evidence for lymphatic Aβ clearance in Alzheimer's transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Amyloid-β efflux from the central nervous system into the plasma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Mechanisms to explain the reverse perivascular transport of solutes out of the brain.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Amyloid beta-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Clearing amyloid through the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1416-1

21 January 2018

Identifiers

10.1007/S00401-015-1416-1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25814152

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25814152

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48260410&oldid=2209266374"